TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
PCVX

Vaxcyte Inc

Healthcare · Biotechnology

58.10$ -3.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Vaxcyte Inc (PCVX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 3,138 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PCVX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,496 1,408 2,091 2,087 3,560 3,511 3,378 3,305 3,172 3,046 3,348 3,138
1,295 1,096 1,517 1,481 2,214 1,788 1,717 1,716 1,767 1,627 1,813 1,553
545 397 612 519 1,050 388 347 307 281 174 261 183
1,266 1,080 1,487 1,453 2,180 1,747 1,672 1,661 1,711 1,561 1,737 1,487
1.9 3.6 0.1 18 18 21 0.1 0.4 47
23 12 -9.5 -18
93 167 107 101 142 205 178 234 279 360 352 380
86 145 87 83 124 140 97 154 200 206 242 271
6.0 7.1 7.2 7.3 9.6 5.9 6.1 6.3 5.8 6.1 6.1 6.5
16 15 22 10 18 48 21 31 49 71 63 101
1,403 1,240 1,984 1,986 3,418 3,306 3,200 3,071 2,893 2,686 2,996 2,758
-744 -924 -1,019 -1,148 -1,251 -1,388 -1,529 -1,696 -1,908 -2,155 -2,476 -2,760
102 104 112 117 124 123 136 136 136 136 140 144

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?